Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result

Ann Allergy Asthma Immunol. 2021 Oct;127(4):498-499. doi: 10.1016/j.anai.2021.07.020. Epub 2021 Jul 31.

Authors

Mitchell M Pitlick¹, Miguel A Park¹, Alexei Gonzalez-Estrada², Sergio E Chiarella³

Affiliations

¹ Division of Allergic Diseases, Mayo Clinic, Rochester, Minnesota.
² Division of Pulmonary, Allergy, and Sleep Medicine, Mayo Clinic, Jacksonville, Florida.
³ Division of Allergic Diseases, Mayo Clinic, Rochester, Minnesota. Electronic address: Chiarella.sergio@mayo.edu.

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anaphylaxis / chemically induced*
BNT162 Vaccine
COVID-19 / immunology
COVID-19 Vaccines / adverse effects*
COVID-19 Vaccines / immunology*
Female
Humans
Polysorbates / adverse effects*
SARS-CoV-2 / immunology
Skin / immunology*
Vaccines, Synthetic / adverse effects*
Vaccines, Synthetic / immunology*
mRNA Vaccines

Substances

COVID-19 Vaccines
Polysorbates
Vaccines, Synthetic
BNT162 Vaccine